Endocrine toxicities of immune checkpoint inhibitors: What differs from other immune-related adverse events

被引：0
|
作者：
Lecoq, A. L. [1 ]
Becquemont, L. [1 ]
Chanson, P. [2 ]
机构：
[1] Hop Bicetre, AP HP, Ctr Rech Clin Paris Saclay, Le Kremlin Bicetre, France
[2] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
immune check point inhibitors; immune-related adverse events; endocrinopathies; hormonal deficiencies;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-078
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [31] Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management
    Pach, J.
    Leventhal, J. S.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (04) : 1 - 20
  • [32] Immune-related adverse events in various organs caused by immune checkpoint inhibitors
    Okiyama, Naoko
    Tanaka, Ryota
    ALLERGOLOGY INTERNATIONAL, 2022, 71 (02) : 169 - 178
  • [33] Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
    Choi, Juwhan
    Lee, Sung Yong
    IMMUNE NETWORK, 2020, 20 (01)
  • [34] INCIDENCE OF MUSCULOSKELETAL AND SKIN IMMUNE-RELATED ADVERSE EVENTS WITH IMMUNE CHECKPOINT INHIBITORS
    Kim, J. H.
    Ng, J.
    Sanmugarajah, J.
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 45 - 46
  • [35] Cutaneous immune-related adverse events to immune checkpoint inhibitors: A dermatology perspective
    Muntyanu, Anastasiya
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB42 - AB42
  • [36] Equibalancing immune-related adverse events and anticancer activity of immune checkpoint inhibitors
    Seeruttun, Sharvesh Raj
    THORACIC CANCER, 2019, 10 (10) : 1855 - 1856
  • [37] Do immune-related adverse events correlate with response to immune checkpoint inhibitors?
    Saleh, Khalil
    Khalife-Saleh, Nadine
    Kourie, Hampig Raphael
    IMMUNOTHERAPY, 2019, 11 (04) : 257 - 259
  • [38] Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?
    Michot, J. M.
    Lazarovici, J.
    Tieu, A.
    Champiat, S.
    Voisin, A. L.
    Ebbo, M.
    Godeau, B.
    Michel, M.
    Ribrag, V.
    Lambotte, O.
    EUROPEAN JOURNAL OF CANCER, 2019, 122 : 72 - 90
  • [39] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Zhong, Li
    Wu, Qing
    Chen, Fuchun
    Liu, Junjin
    Xie, Xianhe
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2559 - 2576
  • [40] Immune-Related Hematologic Adverse Events in the Context of Checkpoint Inhibitors
    Saliba, Antoine
    Xie, Zhuoer
    Higgins, Ally
    Andrade-Gonzalez, Xavier A.
    Fuentes-Bayne, Harry E.
    Hampel, Paul J.
    Fonkoua, Lionel Kankeu
    Childs, Daniel
    Rakshit, Sagar
    Bezerra, Evandro D.
    Lou, Yanyan
    Rivera, Candido E.
    Price, Katharine
    Yan, Yiyi
    Schwecke, Anna
    Block, Matthew S.
    Thanarajasingam, Uma
    Thanarajasingam, Gita
    Wolanskyj, Alexandra P.
    Marshall, Ariela L.
    Kottschade, Lisa A.
    Go, Ronald S.
    Al-Kali, Aref
    BLOOD, 2020, 136
12345